The prognostic significance of the serum biomarker heart-fatty acidic binding protein in comparison with S100b in severe traumatic brain injury

Journal of Neurotrauma

Volumn 30, Issue 19, 2013, Pages 1631-1637

  Walder, Bernhard ^a   Robin, Xavier ^b   Rebetez, Marie My Lien ^a   Copin, Jean Christophe ^a,b   Gasche, Yvan ^a,b   Sanchez, Jean Charles ^b   Turck, Natacha ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

blood biomarkers; outcome prediction; traumatic brain injury

Indexed keywords

FATTY ACID BINDING PROTEIN; HEART FATTY ACIDIC BINDING PROTEIN; PROTEIN S100B; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW COMA SCALE; HUMAN; INJURY SCALE; MALE; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN INJURIES; FATTY ACID-BINDING PROTEINS; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE TRAUMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; TREATMENT OUTCOME; UNCONSCIOUSNESS; YOUNG ADULT;

EID: 84885138738     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2012.2791     Document Type: Article

References (42)

1. van Velzen, J.M., van Bennekom, C.A., Edelaar, M.J., Sluiter, J.K., and Frings-Dresen, M.H. (2009). How many people return to work after acquired brain injury?: A systematic review. Brain Inj. 23, 473-488.
2. Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H.U., and Jonsson, B. (2012). The economic cost of brain disorders in Europe. Eur. J. Neurol. 19, 155-162.
3. Masson, F., Thicoipe, M., Aye, P., Mokni, T., Senjean, P., Schmitt, V., Dessalles, P.H., Cazaugade, M., and Labadens, P. (2001). Epidemiology of severe brain injuries: A prospective population-based study. J. Trauma 51, 481-489.
4. Bouillon, B., Raum, M., Fach, H., Buchheister, B., Lefering, R., Menzel, J., and Klug, N. (1999). The incidence and outcome of severe brain trauma-design and first results of an epidemiological study in an urban area. Restor. Neurol. Neurosci. 14, 85-92.
5. Andriessen, T.M., Horn, J., Franschman, G., van der Naalt, J., Haitsma, I., Jacobs, B., Steyerberg, E.W., and Vos, P.E. (2011). Epidemiology, severity classification, and outcome of moderate and severe traumatic brain injury: A prospective multicenter study. J. Neurotrauma 28, 2019-2031.
6. Murray, G.D., Teasdale, G.M., Braakman, R., Cohadon, F., Dearden, M., Iannotti, F., Karimi, A., Lapierre, F., Maas, A., Ohman, J., Persson, L., Servadei, F., Stocchetti, N., Trojanowski, T., and Unterberg, A. (1999). The European Brain Injury Consortium survey of head injuries. Acta Neurochir. (Wien) 141, 223-236.
7. von Elm, E., Osterwalder, J.J., Graber, C., Schoettker, P., Stocker, R., Zangger, P., Vuadens, P., Egger, M., and Walder, B. (2008). Severe traumatic brain injury in Switzerland-feasibility and first results of a cohort study. Swiss Med. Wkly. 138, 327-334.
8. Roozenbeek, B., Chiu, Y.L., Lingsma, H.F., Gerber, L.M., Steyerberg, E.W., Ghajar, J., and Maas, A.I. (2012). Predicting 14-day mortality after severe traumatic brain injury: Application of the IMPACT models in the brain trauma foundation TBI-trac(R) New York State database. J. Neurotrauma 29, 1306-1312.
9. Zuercher, M., Ummenhofer, W., Baltussen, A., and Walder, B. (2009). The use of Glasgow Coma Scale in injury assessment: A critical review. Brain Inj. 23, 371-384.
10. Stein, D.M., Lindell, A.L., Murdock, K.R., Kufera, J.A., Menaker, J., Bochicchio, G.V., Aarabi, B., and Scalea, T.M. (2012). Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury. J. Neurotrauma 29, 1140-1149.
11. Bohmer, A.E., Oses, J.P., Schmidt, A.P., Peron, C.S., Krebs, C.L., Oppitz, P.P., D'Avila, T.T., Souza, D.O., Portela, L.V., and Stefani, M.A. (2011). Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery 68, 1624-1630; discussion, 1630-1631.
12. Mondello, S., Jeromin, A., Buki, A., Bullock, R., Czeiter, E., Kovacs, N., Barzo, P., Schmid, K., Tortella, F., Wang, K.K., and Hayes, R.L. (2012). Glial neuronal ratio: A novel index for differentiating injury type in patients with severe traumatic brain injury. J. Neurotrauma 29, 1096-1104.
13. Gullo Jda, S., Bertotti, M.M., Silva, C.C., Schwarzbold, M., Diaz, A.P., Soares, F.M., Freitas, F.C., Nunes, J., Pinheiro, J.T., Morato, E.F., Prediger, R.D., Linhares, M.N., and Walz, R. (2011). Hospital mortality of patients with severe traumatic brain injury is associated with serum PTX3 levels. Neurocrit. Care 14, 194-199.
14. Ley, E.J., Clond, M.A., Singer, M.B., Shouhed, D., and Salim, A. (2011). IL6 deficiency affects function after traumatic brain injury. J. Surg. Res. 170, 253-256.
15. Helmy, A., Carpenter, K.L., Menon, D.K., Pickard, J.D., and Hutchinson, P.J. (2011). The cytokine response to human traumatic brain injury: Temporal profiles and evidence for cerebral parenchymal production. J. Cereb. Blood Flow Metab. 31, 658-670.
16. Lin, Z., Han, M., Li, H., Luo, H., Zhang, Y., and Luo, W. (2011). Soluble vascular adhesion protein-1: Decreased activity in the plasma of trauma victims and predictive marker for severity of traumatic brain injury. Clin. Chim. Acta. 412, 1678-1682.
17. McKeating, E.G., Andrews, P.J., and Mascia, L. (1998). Leukocyte adhesion molecule profiles and outcome after traumatic brain injury. Acta Neurochir. Suppl. 71, 200-202.
18. Schiavi, P., Laccarino, C., and Servadei, F. (2012). The value of the calcium binding protein S100 in the management of patients with traumatic brain injury. Acta Biomed. 83, 5-20.
19. Topolovec-Vranic, J., Pollmann-Mudryj, M.A., Ouchterlony, D., Klein, D., Spence, J., Romaschin, A., Rhind, S., Tien, H.C., and Baker, A.J. (2011). The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury. J. Trauma 71, 5 Suppl, 1, S478-S486.
20. Kleindienst, A., Schmidt, C., Parsch, H., Emtmann, I., Xu, Y., and Buchfelder, M. (2010). The passage of S100B from brain to blood is not specifically related to the blood-brain barrier integrity. Cardiovasc. Psychiatry Neurol. 2010, 801295.
21. Sofijanova, A., Piperkova, K., and Al Khalili, D. (2012). Predicting outcome after severe brain injury in risk neonates using the serum S100B biomarker: Results using single (24h) time-point. Prilozi 33, 147-156.
22. Vos, P.E., Jacobs, B., Andriessen, T.M., Lamers, K.J., Borm, G.F., Beems, T., Edwards, M., Rosmalen, C.F., and Vissers, J.L. (2010). GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study. Neurology 75, 1786-1793.
23. Morochovic, R., Racz, O., Kitka, M., Pingorova, S., Cibur, P., Tomkova, D., and Lenartova, R. (2009). Serum S100B protein in early management of patients after mild traumatic brain injury. Eur. J. Neurol. 16, 1112-1117.
24. Rainey, T., Lesko, M., Sacho, R., Lecky, F., and Childs, C. (2009). Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: Results using a single (24h) time-point. Resuscitation 80, 341-345.
25. Piazza, O., Storti, M.P., Cotena, S., Stoppa, F., Perrotta, D., Esposito, G., Pirozzi, N., and Tufano, R. (2007). S100B is not a reliable prognostic index in paediatric TBI. Pediatr. Neurosurg. 43, 258-264.
26. Alhadi, H.A. and Fox, K.A. (2004). Do we need additional markers of myocyte necrosis: The potential value of heart fatty-acid-binding protein. QJM 97, 187-198.
27. Muehlschlegel, J.D., Perry, T.E., Liu, K.Y., Fox, A.A., Collard, C.D., Shernan, S.K., and Body, S.C. (2010). Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery. Anesth. Analg. 111, 1101-1109.
28. Zimmermann-Ivol, C.G., Burkhard, P.R., Le Floch-Rohr, J., Allard, L., Hochstrasser, D.F., and Sanchez, J.C. (2004). Fatty acid binding protein as a serum marker for the early diagnosis of stroke: A pilot study. Mol. Cell. Proteomics 3, 66-72.
29. Wunderlich, M.T., Hanhoff, T., Goertler, M., Spener, F., Glatz, J.F., Wallesch, C.W., and Pelsers, M.M. (2005). Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke. J. Neurol. 252, 718-724.
30. Garthe, E., States, J.D., and Mango, N.K. (1999). Abbreviated injury scale unification: The case for a unified injury system for global use. J. Trauma 47, 309-323.
31. Wilson, J.T., Edwards, P., Fiddes, H., Stewart, E., and Teasdale, G.M. (2002). Reliability of postal questionnaires for the Glasgow Outcome Scale. J. Neurotrauma 19, 999-1005.
32. Dinh, W., Nickl, W., Futh, R., Lankisch, M., Hess, G., Zdunek, D., Scheffold, T., Barroso, M.C., Tiroch, K., Ziegler, D., and Seyfarth, M. (2011). High sensitive troponin T and heart fatty acid binding protein: Novel biomarker in heart failure with normal ejection fraction? A cross-sectional study. BMC Cardiovasc. Disord. 11, 41.
33. Okamoto, F., Sohmiya, K., Ohkaru, Y., Kawamura, K., Asayama, K., Kimura, H., Nishimura, S., Ishii, H., Sunahara, N., and Tanaka, T. (2000). Human heart-type cytoplasmic fatty acid-binding protein (HFABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin. Chem. Lab. Med. 38, 231-238.
34. Ben Abdesselam, O., Vally, J., Adem, C., Foglietti, M.J., and Beaudeux, J.L. (2003). Reference values for serum S-100B protein depend on the race of individuals. Clin. Chem. 49, 836-837.
35. Garcia-Valdecasas, S., Ruiz-Alvarez, M.J., Garcia De Tena, J., De Pablo, R., Huerta, I., Barrionuevo, M., Coca, C., and Arribas, I. (2011). Diagnostic and prognostic value of heart-type fatty acid-binding protein in the early hours of acute myocardial infarction. Acta Cardiol. 66, 315-321.
36. Turck, N., Vutskits, L., Sanchez-Pena, P., Robin, X., Hainard, A., Gex-Fabry, M., Fouda, C., Bassem, H., Mueller, M., Lisacek, F., Puybasset, L., an Sanchez, J.C. (2010). A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage. Intensive Care Med. 36, 107-115.
37. Zanier, E.R., Longhi, L., Fiorini, M., Cracco, L., Bersano, A., Zoerle, T., Branca, V., Monaco, S., and Stocchetti, N. (2008). Increased levels of CSF heart-type fatty acid-binding protein and tau protein after aneurysmal subarachnoid hemorrhage. Acta Neurochir. Suppl. 102, 339-343.
38. McCann, C.J., Glover, B.M., Menown, I.B., Moore, M.J., McEneny, J., Owens, C.G., Smith, B., Sharpe, P.C., Young, I.S., and Adgey, J.A. (2009). Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain. Am. J. Cardiol. 103, 22-28.
39. Inoue, K., Suwa, S., Ohta, H., Itoh, S., Maruyama, S., Masuda, N., Sugita, M., and Daida, H. (2011). Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain. Circ. J. 75, 2813-2820.
40. Liu, R.Z., Mita, R., Beaulieu, M., Gao, Z., and Godbout, R. (2010). Fatty acid binding proteins in brain development and disease. Int. J. Dev. Biol. 54, 1229-1239.
41. Farias, S.E., Heidenreich, K.A., Wohlauer, M.V., Murphy, R.C., and Moore, E.E. (2011). Lipid mediators in cerebral spinal fluid of traumatic brain injured patients. J. Trauma 71, 1211-1218.
42. Pielmaier, L., Walder, B., Rebetez, M.M., and Maercker, A. (2011). Post-traumatic stress symptoms in relatives in the first weeks after severe traumatic brain injury. Brain Inj. 25, 259-265.